Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges

Clinical Infectious Diseases

Volumn 62, Issue 8, 2016, Pages 1043-1048

  Roberts, Teri ^a   Cohn, Jennifer ^a   Bonner, Kimberly ^a   Hargreaves, Sally ^b  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

antiretroviral therapy; monitoring; resource limited settings; viral load; virological

Indexed keywords

ANTIVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; CHRONIC PATIENT; COST EFFECTIVENESS ANALYSIS; DEVELOPED COUNTRY; DRIED BLOOD SPOT TESTING; DRUG TREATMENT FAILURE; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LABORATORY; MEDICATION COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCALE UP; TREATMENT DURATION; VIRAL LOAD TESTING; VIRUS LOAD; WORLD HEALTH ORGANIZATION; CD4 LYMPHOCYTE COUNT; DRUG MONITORING; ECONOMICS; HEALTH CARE PLANNING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; INDIA; POINT OF CARE SYSTEM; STANDARDS; VIROLOGY;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DRUG MONITORING; HEALTH PLAN IMPLEMENTATION; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; INDIA; POINT-OF-CARE SYSTEMS; VIRAL LOAD; WORLD HEALTH ORGANIZATION;

EID: 84964806345     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw001     Document Type: Article

References (36)

1. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. Geneva, Switzerland: WHO, 2013. Available at: http://www.who.int/hiv/pub/guidelines/arv2013/en/. Accessed 15 September 2014.
2. World Health Organization. March 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. Geneva, Switzerland: WHO, 2014.
3. Sigaloff KCE, Hamers RL, Wallis CL, et al. Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa. J Acquir Immune Defic Syndr 2011; 58: 23-31.
4. Keiser O, Chi B, Gsponer T, et al. Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa. AIDS 2011; 25:1761-9.
5. Rowley CF. Developments in CD4 and viral load monitoring in resource-limited settings. Clin Infect Dis 2014; 58:407-12.
6. Roberts T, Bygrave H, Fajardo E, Ford N. Challenges and opportunities for the implementation of virological testing in resource-limited settings. J Int AIDS Soc 2012; 15:17324.
7. World Health Organization. Technical and operational considerations for implementing HIV viral load testing. Geneva, Switzerland: WHO, 2014.
8. Working Group on Modelling of ART Monitoring Strategies in Sub-Saharan Africa. Sustainable HIV treatment in Africa through viral load-informed differentiated care. Nature 2015; 528:S68-76.
9. Venables E, Giuliani R, Sebastiani T, et al. Viral load monitoring and second line therapy: do clinicians switch failing patients? [abstract PUB019]. In: 20th International AIDS Conference, 2014.
10. African Society for Laboratory Medicine. Viral load monitoring in African HIV treatment programmes. Cape Town, South Africa: ASLM, 2013. Available at: http://saafrica.org/viral-load-testing-in-african-hiv-treatment-programmes/. Accessed October 2015.
11. Lecher S, Ellenberger D, Kim A, et al. Scale-up of HIV viral load monitoring-seven sub-Saharan African countries. MMWR Morb Mortal Wkly Rep 2015; 64:1287-90.
12. UNITAID. UNITAID HIV/AIDS diagnostic landscape. Available at: http://www.unitaid.eu/images/marketdynamics/publications/UNITAID-2015-Semi-annual-Update-HIV-Diagnostics-Technology-Landscape.pdf. Accessed November 2015.
13. Médecins Sans Frontières. Achieving undetectable: what questions remain in scaling-up HIV virological treatment monitoring? MSF undetectable volume 6. Geneva, Switzerland: MSF Access Campaign, 2014.
14. Médecins Sans Frontières. Getting to undetectable: usage of HIV viral load monitoring in five countries: MSF undetectable volume 5. Geneva, Switzerland, MSF Access Campaign, 2014.
15. World Health Organization. The availability and use of diagnostics for HIV: a 2012/2013 WHO survey of low- and middle-income countries. Geneva, Switzerland: WHO, 2014.
16. Vogt F, Tayler-Smith K, Bernasconi A, et al. Access to CD4 testing for rural HIV patients: findings from a cohort study in Zimbabwe. PLoS One 2015; 10:e0129166.
17. Eholie S, Aoussi F, Ouattara I, Bissagnene E, Anglaret X. HIV treatment and care in resource-constrained environments-challenges for the next decade. J Int AIDS Soc 2012; 15:17334.
18. Stevens W, Marshall T. Challenges in implementing viral load testing in South Africa. J Infect Dis 2010; 201(suppl 1):S78-84.
19. Jean Louis F, Osborne AJ, Elias VJ, et al. Specimen referral network to rapidly scale-up CD4 testing: the hub and spoke model for Haiti. J AIDS Clin Res 2015; 6:488.
20. Implementing services for early infant diagnosis (EID) of HIV: a comparative descriptive analysis of national programs in four countries. BMC Public Health 2011; 11:553.
21. Médecins Sans Frontières. Putting HIV treatment to the test: a product guide for viral load and point-of-care CD4 diagnostic tools. Geneva, Switzerland: MSF Access Campaign, 2013.
22. Hyle EP, Jani IV, Lehe J, et al. The clinical and economic impact of point-of-care CD4 testing in Mozambique and other resource-limited settings: a cost-effectiveness analysis. PLoS Med 2014; 11:e1001725.
23. Larson B, Schnippel K, Ndibongo B, et al. Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa. J Acquir Immune Defic Syndr 2012; 61:e13-7.
24. Laursen L. Point-of-care tests poised to alter course of HIV treatment. Nat Med 2012; 18:1156.
25. Seidenberg P, Nicholson S, Schaefer M, et al. Early infant diagnosis of HIV infection in Zambia through mobile phone texting of blood test results. Bull World Health Organ 2012; 90:348-56.
26. Kiyaga C, Sendagire H, Joseph E, et al. Uganda's new national laboratory sample transport system: a successful model for improving access to diagnostic services for early infant HIV diagnosis and other programs. PLoS One 2013; 8:e78609.
27. Médecins Sans Frontières. How low can we go? Pricing for HIV viral load testing in low- and middle-income countries. Geneva, Switzerland: MSF Access Campaign, 2013.
28. Global Fund. Strategic reviews in sourcing and market dynamics. Available at: http://www.theglobalfund.org/en/p4i/events/. Accessed November 2015.
29. Pannus P, Fajardo E, Metcalf C, et al. Pooled HIV-1 viral load testing using dried blood spots to reduce the cost of monitoring antiretroviral treatment in a resourcelimited setting. J Acquir Immune Defic Syndr 2013; 64:134-7.
30. Bonner K, Mezochow A, Roberts T, Ford N, Cohn J. Viral load monitoring as a toll to reinforce adherence: a systematic review. J Acquir Immune Defic Syndr 2013; 64:74-8.
31. Ford N, Meintjes G, Pozniak A, et al. The future role of CD4 cell count for monitoring antiretroviral therapy. Lancet Infect Dis 2014; 15:241-7.
32. Sax PE. Can we break the habit of routine CD4 monitoring in HIV care? Clin Infect Dis 2013; 56:1344-6.
33. INSIGHT START study group. Initiation of antiretroviral therapy in asymptomatic HIV infection. N Engl J Med 2015; 373:795.
34. Hamer RL, Sawyer AW, Tuohy M, et al. Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis. AIDS 2012; 26:1663-72.
35. Estill J, Egger M, Blaser N, et al. Cost-effectiveness of point-of-care viral load monitoring of ART in resource-limited settings: mathematical modeling study. AIDS 2013; 27:1483-92.
36. Jobanputra, Parker LA, Azih C, et al. Impact and programmatic implications of routine viral load monitoring in Swaziland. J Acquir Immune Defic Syndr 2014; 67:45-51.